AMPCO-PITTSBURGH CORP (AP)

US0320371034 - Common Stock

1.87  +0.03 (+1.63%)

Fundamental Rating

1

AP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 157 industry peers in the Metals & Mining industry. AP has a bad profitability rating. Also its financial health evaluation is rather negative. AP does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

AP had negative earnings in the past year.
The reported net income has been mixed in the past 5 years: AP reported negative net income in multiple years.
In the past 5 years AP reported 4 times negative operating cash flow.

1.2 Ratios

The Return On Assets of AP (-7.44%) is worse than 66.24% of its industry peers.
AP has a Return On Equity of -71.91%. This is amonst the worse of the industry: AP underperforms 87.26% of its industry peers.
AP has a Return On Invested Capital of 0.98%. This is comparable to the rest of the industry: AP outperforms 47.13% of its industry peers.
AP had an Average Return On Invested Capital over the past 3 years of 0.54%. This is significantly below the industry average of 8.55%.
The 3 year average ROIC (0.54%) for AP is below the current ROIC(0.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -7.44%
ROE -71.91%
ROIC 0.98%
ROA(3y)-2.38%
ROA(5y)-1.91%
ROE(3y)-22.02%
ROE(5y)-19.71%
ROIC(3y)0.54%
ROIC(5y)N/A

1.3 Margins

AP's Operating Margin of 1.38% is in line compared to the rest of the industry. AP outperforms 45.86% of its industry peers.
In the last couple of years the Operating Margin of AP has declined.
AP has a Gross Margin (17.47%) which is in line with its industry peers.
AP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.38%
PM (TTM) N/A
GM 17.47%
OM growth 3Y-12.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.52%
GM growth 5Y1.84%

1

2. Health

2.1 Basic Checks

AP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AP has been increased compared to 1 year ago.
Compared to 5 years ago, AP has more shares outstanding
AP has a worse debt/assets ratio than last year.

2.2 Solvency

AP has an Altman-Z score of 0.93. This is a bad value and indicates that AP is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.93, AP is doing worse than 73.25% of the companies in the same industry.
A Debt/Equity ratio of 2.06 is on the high side and indicates that AP has dependencies on debt financing.
The Debt to Equity ratio of AP (2.06) is worse than 94.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF N/A
Altman-Z 0.93
ROIC/WACC0.13
WACC7.39%

2.3 Liquidity

AP has a Current Ratio of 1.98. This is a normal value and indicates that AP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AP (1.98) is comparable to the rest of the industry.
AP has a Quick Ratio of 1.02. This is a normal value and indicates that AP is financially healthy and should not expect problems in meeting its short term obligations.
AP has a Quick ratio of 1.02. This is in the lower half of the industry: AP underperforms 67.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.02

1

3. Growth

3.1 Past

AP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1612.24%.
The Revenue has been growing slightly by 6.52% in the past year.
Measured over the past years, AP shows a small growth in Revenue. The Revenue has been growing by 0.14% on average per year.
EPS 1Y (TTM)-1612.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%406.15%
Revenue 1Y (TTM)6.52%
Revenue growth 3Y8.74%
Revenue growth 5Y0.14%
Sales Q2Q%3.53%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AP indicates a somewhat cheap valuation: AP is cheaper than 68.79% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.96

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AP!.
Industry RankSector Rank
Dividend Yield N/A

AMPCO-PITTSBURGH CORP

NYSE:AP (9/6/2024, 8:04:00 PM)

1.87

+0.03 (+1.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap37.57M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.44%
ROE -71.91%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.38%
PM (TTM) N/A
GM 17.47%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.98
Quick Ratio 1.02
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1612.24%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.52%
Revenue growth 3Y8.74%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y